SCHEMBL4229405

SCHEMBL4229405

CCOCCOc1cc(C=C(OCC)C(=O)O)ccc1I

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 3/20 0.41
POLB P06746 1/20 0.37
TTR P02766 1/20 0.37
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 6/20 0.36
KMT2A Q03164 6/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 5/20 0.35
MAPT P10636 4/20 0.34
APP P05067 1/20 0.34
LMNA P02545 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
S1PR4 O95977 1/20 0.34
S1PR1 P21453 1/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4229399 1.00 FDPS (0.41) FDPSPOLBTTRKDM4EALDH1A1
SCHEMBL4211072 0.91 FDPS (0.41) FDPSPOLBKDM4EALDH1A1KMT2A
SCHEMBL4211071 0.91 FDPS (0.41) FDPSPOLBKDM4EALDH1A1KMT2A
SCHEMBL4218505 0.91 KDM4E (0.39) FDPSPOLBKDM4EALDH1A1KMT2A
SCHEMBL4218498 0.91 KDM4E (0.39) FDPSPOLBKDM4EALDH1A1KMT2A
SCHEMBL4223934 0.91 KDM4E (0.39) FDPSPOLBKDM4EALDH1A1KMT2A
SCHEMBL4220323 0.89 ALOX5 (0.40) FDPSPOLBTTRKDM4EALDH1A1
SCHEMBL4220328 0.89 ALOX5 (0.40) FDPSPOLBTTRKDM4EALDH1A1
SCHEMBL4220330 0.89 ALOX5 (0.40) FDPSPOLBTTRKDM4EALDH1A1
SCHEMBL4607835 0.85 AKR1C3 (0.39) FDPSPOLBKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383652-B2 Biaromatic compounds that modulate PPAR-receptors GALDERMA RESEARCH & DEVELOPMENT (FR) 2013-02-26 US disclosed
US-20090012129-A1 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPAR-RECEPTORS GALDERMA RESEARCH & DEVELOPMENT (FR) 2009-01-08 US disclosed
EP-1943213-A2 PPAR MODULATING BIAROMATIC COMPOUNDS Galderma Research & Development (FR) 2008-07-16 EP disclosed
WO-2007049158-A2 PPAR MODULATING BIAROMATIC COMPOUNDS GALDERMA RESEARCH & DEVELOPMENT (FR) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012129-A1 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPAR-RECEPTORS PPARG, PPARD, PPARA FDPS 2252/4885POLB 1106/4885TTR 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.